← Eichor
Study identifier: NCT06692894 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

Condition: Myelodysplastic Syndromes, Adult  ·  Sponsor: University of Vermont

PhaseN/A
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Why Is This Research Study Being Conducted? * The study wants to find out why people with a type of blood cancer called myelodysplastic syndromes (MDS) are more likely to have heart problems like heart disease and stroke. * Researchers also want to see if certain proteins related to inflammation in the body can help predict these heart issues in MDS patients. * By understanding this better, researchers hope to find new ways to detect and manage heart disease risks in people with MDS

This description comes directly from the study's public registry record.

Talk to the study team

Diego Adrianzen Herrera, MD  ·  (802) 656-2021  ·  dadrianz@med.uvm.edu

Neil A Zakai, MD  ·  (802) 656-2021  ·  neil.zakai@med.uvm.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of VermontBurlington, Vermont, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06692894